Dr. Behnaz Rouhani, MD

Dr. Rouhani practices at Harvard Eye Associates in Laguna Hills, California.

Dr. Rouhani's NPI, 1205157484, was assigned on June 22, 2010. Dr. Rouhani graduated from Shahid Beheshti University of Medical Sciences in 2003. Dr. Rouhani holds California license A145055.

Dr. Rouhani's primary practice is Harvard Eye Associates, at 23961 Calle De Magdalena, Laguna Hills, CA 92653 in Orange County. The practice phone is (949) 951-2020.

Dr. Rouhani's primary practice is Harvard Eye Associates in Laguna Hills, California. Dmand AI also links Dr. Rouhani to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rouhani practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Rouhani's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Rouhani is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Rouhani's licenses on file in 3 states: California, New York and Pennsylvania.

Dmand AI lists cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Rouhani treats.

CMS data shows 2,768 Medicare services from Dr. Rouhani across 24 procedure codes in 2024, for 631 Medicare patients. Medicare paid $260,319 for them.

CMS counts 631 Medicare patients who saw Dr. Rouhani in 2024. The largest group is 75 to 84, with 276 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rouhani's median patient age at 72, with 63% women.

In 2024, Dr. Rouhani wrote 1,055 Medicare Part D claims for 339 patients. 49% of them were for generic drugs. CMS names the drug for 944 of them, across 21 drugs with 11 or more claims each, at $197,491 in total drug cost. In 2023, CMS named 810 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Rouhani for performance year 2024, reported as part of a group. Dr. Rouhani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 251 procedures of cataract surgery by Dr. Rouhani, more than 87% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Rouhani. Dr. Rouhani's most frequent co-authors are Robert Jackson Courtney, MD and Aparna Ramasubramanian, MD.

CMS Open Payments shows 72 general payments to Dr. Rouhani from 16 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 54% of the total. TissueTech, Inc. paid the most, $2,059.

Dr. Rouhani graduated from Shahid Beheshti University of Medical Sciences in 2003.

Dr. Rouhani is in network with 22 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.